We investigated in detail the associations between renal dysfunction and the intake frequency of aldosterone receptor blockers, since hyperkalemia due to spironolactone poses a relevant risk in heart failure therapy [11]. This evidence concerns the gene NR3C2 and Hyperkalemia.